Home / Famotidine / Czechia
CZ ATC A02BA03 · updated 2 Nov 2026
Famotidine shortage in Czechia
Is there a Famotidine shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Famotidine product is reported short in Czechia. The company estimate for the return is 7 Dec 2026. Main reason: manufacturing problem.
Also short in Canada, Ireland, Japan. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | FAMOSAN 20MG 20MG TBL FLM 50 anticipated | PRO.MED.CS Praha a.s. | 6 Nov 2026 | 7 Dec 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.